Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             222 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adaptive radiation therapy for breast IMRT-simultaneously integrated boost: Three-year clinical experience Hurkmans, Coen W.
2012
103 Supplement 2 p. 183-187
5 p.
artikel
2 A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis Terashima, Kazuki
2012
103 Supplement 2 p. 25-31
7 p.
artikel
3 Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer Crehange, Gilles
2012
103 Supplement 2 p. 244-246
3 p.
artikel
4 Clinical target volumes in anal cancer: Calculating what dose was likely to have been delivered in the UK ACT II trial protocol Aggarwal, Ajay
2012
103 Supplement 2 p. 341-346
6 p.
artikel
5 Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery Terrazzino, Salvatore
2012
103 Supplement 2 p. 199-205
7 p.
artikel
6 Comparison of 3D conformal breast radiation treatment plans using the anisotropic analytical algorithm and pencil beam convolution algorithm Yoo, Sua
2012
103 Supplement 2 p. 172-177
6 p.
artikel
7 Dose–response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer Bhide, Shreerang A.
2012
103 Supplement 2 p. 88-91
4 p.
artikel
8 Editorial Board 2012
103 Supplement 2 p. ii-
1 p.
artikel
9 Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: A randomized controlled trial in prostate cancer patients undergoing radiotherapy Pettersson, Anna
2012
103 Supplement 2 p. 333-340
8 p.
artikel
10 Ensuring the integrity of treatment parameters throughout the radiotherapy process Nordström, Fredrik
2012
103 Supplement 2 p. 299-304
6 p.
artikel
11 EP-1413 ACCEPTANCE TESTS PROCEDURE VERSUS CLINICAL IMAGING QUALITY ASSURANCE FOR KV-CBCT IMAGE SYSTEM Galhardas, J.
2012
103 Supplement 2 p. S537-S538
2 p.
artikel
12 EP-1622 ANAHIS: A SOFTWARE TOOL FOR GETTING DOSIMETRIC DATA FROM TOMOTHERAPY HISTOGRAMS ACCORDING TO ICRU REPORT NO. 83 De Sena Espinel, E.
2012
103 Supplement 2 p. S620-
1 p.
artikel
13 EP-1430 ANALYSIS OF CHANGES IN DOSE DISTRIBUTION DUE TO RESPIRATION DURING IMRT Shin, J.S.
2012
103 Supplement 2 p. S545-
1 p.
artikel
14 EP-1118 ASSESSMENT OF STABILITY OF GOLD ANCHOR™ FIDUCIAL MARKER IMPLANTS IN THE PROSTATE Kukielka, A.
2012
103 Supplement 2 p. S432-
1 p.
artikel
15 EP-1207 BENEFIT OF SYSTEMATIC RAPIDARC RE-PLANNING AND ADAPTIVE TREATMENT OF NASOPHARYNGEAL CANCER Khan, M.
2012
103 Supplement 2 p. S464-
1 p.
artikel
16 EP-1399 CLINICAL EXPERIENCE OF REAL-TIME TRACKING WITH THE RAYPILOT SYSTEM IN PATIENTS WITH PROSTATE CANCER Lindencrona, U.
2012
103 Supplement 2 p. S531-
1 p.
artikel
17 EP-1502 CLINICAL INTRODUCTION OF TREATMENT PLANNING GUIDED HYPERTHERMIA: A COMPLAINT ADAPTIVE APPROACH Canters, R.
2012
103 Supplement 2 p. S575-
1 p.
artikel
18 EP-1149 CLINICAL RESULTS IN RADIOTHERAPY ALONE OR CHEMORADIOTHERAPY FOR SQUAMAOUS CELL CARCINOMA OF THE UTERINE CERVIX Chang, T.
2012
103 Supplement 2 p. S443-S444
2 p.
artikel
19 EP-1591 COMBINED EFFECT OF HYPERTHERMIA AND A NEW HSP70 INHIBITOR, PIFITHRIN-µ, ON PROSTATE CANCER Sekihara, K.
2012
103 Supplement 2 p. S610-
1 p.
artikel
20 EP-1209 COMPARISON OF A STANDARD 2-FIELD TECHNIQUE WITH IMRT AND VMAT FOR THE TREATMENT OF T1 AND SMALL T2 LARYNGEAL TUMOURS Verhoef, C.G.
2012
103 Supplement 2 p. S465-
1 p.
artikel
21 EP-1519 COMPARISON OF FULL-ARC AND HALF-ARC VOLUMETRIC MODULATED ARC THERAPY (VMAT) FOR MAXILLARY CANCER Miura, H.
2012
103 Supplement 2 p. S582-
1 p.
artikel
22 EP-1447 COMPREHENSIVE LINEAR ACCELERATOR QA USING COMMERCIAL ANALYTIC SOFTWARE APLICATION Matsumoto, K.
2012
103 Supplement 2 p. S552-
1 p.
artikel
23 EP-1471 DEMONS REGISTRATION OF CT VOLUME AND CBCT PROJECTIONS FOR ADAPTIVE RADIOTHERAPY: AVOIDING CBCT RECONSTRUCTION Bjerre, T.
2012
103 Supplement 2 p. S561-S562
2 p.
artikel
24 EP-1070 DOES ADVANCED TECHNIQUE ALLOW A DOSE ESCALATION IN NEOADJUVANT RADIOTHERAPY OF ESOPHAGEAL CARCINOMA? Fakhrian, K.
2012
103 Supplement 2 p. S416-
1 p.
artikel
25 EP-1516 DOSE ESCALATION IN MRI GUIDED PREOPERATIVE ACCELERATED PARTIAL BREAST RADIOTHERAPY Doganos, D.
2012
103 Supplement 2 p. S581-
1 p.
artikel
26 EP-0995 DOSIMETRIC COMPARISION OF ELECTRON AND X-RAY FOR THE TREATMENT OF TUMOR BED BOOST IN BREAST CONSERVING SURGERY Park, S.
2012
103 Supplement 2 p. S392-
1 p.
artikel
27 EP-1355 DOSIMETRIC STUDY OF VALENCIA SURFACE APPLICATORS Ferrer, C.
2012
103 Supplement 2 p. S514-
1 p.
artikel
28 EP-1368 EVALUATION OF NEUTRON DOSE IN CENTRAL AXIS ABSORBED DOSE IN LINAC MACHINES BY TLD600 AND TLD700 DOSIMETERS Darestani, H.
2012
103 Supplement 2 p. S519-
1 p.
artikel
29 EP-0975 EVALUATION OF P21 GENE MUTATION IN PATIENTS WITH TRIPLE NEGATIVE AND ER(−), PR(−), HER-2(+) BREAST CANCER Özen, A.
2012
103 Supplement 2 p. S385-
1 p.
artikel
30 EP-1461 EVALUATION OF TWO METHODS TO ESTIMATE RESPIRATORY INDUCED MOTION OF LUNG TUMOURS IN 4DCT SCANS Nygaard, D.E.
2012
103 Supplement 2 p. S557-S558
2 p.
artikel
31 EP-1238 EXPERIENCE IN THE RADIOTHERAPY OF SPONTANEOUS TUMOURS IN PETS Courdi, A.
2012
103 Supplement 2 p. S474-
1 p.
artikel
32 EP-1564 EXTENDING TREATMENT FIELD SIZE USING VMAT AND MULTIPLE ISOCENTERS Perez-Rozos, A.
2012
103 Supplement 2 p. S600-
1 p.
artikel
33 EP-1190 FDG SUVMAX NOT ASSOCIATED WITH RECURRENCE RISK IN 28 CASES AND 28 MATCHED CONTROLS TREATED FOR HEAD AND NECK CANCER Rasmussen, J.
2012
103 Supplement 2 p. S457-S458
2 p.
artikel
34 EP-1396 FEASIBILITY OF HIPPOCAMPAL-SPARING WHOLE-BRAIN RADIOTHERAPY USING ELEKTA EQUIPMENT Nevelsky, A.
2012
103 Supplement 2 p. S530-
1 p.
artikel
35 EP-1012 FREE BREATHING GATING IS SUPERIOR TO PRONE POSITION FOR WHOLE BREAST RADIOTHERAPY Sweldens, C.
2012
103 Supplement 2 p. S398-
1 p.
artikel
36 EP-1324 HELICAL DIODE ARRAY DOSE DISTRIBUTIONS VERSUS RADIOGRAPHIC FILM MEASUREMENTS IN ISOCENTRIC PLANES Luna, R. Bermúdez
2012
103 Supplement 2 p. S502-S503
2 p.
artikel
37 EP-0998 HYPOFRACTIONATED ACCELERATED RADIOTHERAPY OF THE BREAST AND NODES FOR CONSERVATIVELY TREATED BREAST CANCER García, L.
2012
103 Supplement 2 p. S393-
1 p.
artikel
38 EP-1266 HYPOFRACTIONATED PALLIATIVE RADIOTHERAPY FOR HEAD AND NECK CANCER Arrabal, M.P. Vargas
2012
103 Supplement 2 p. S483-
1 p.
artikel
39 EP-1550 IMPACT OF BLADDER DISTENSION ON ORGANS AT RISK IN 3D INTRACAVITARY BRACHYTHERAPY FOR GYNECOLOGICAL CANCER Bajwa, H.
2012
103 Supplement 2 p. S595-
1 p.
artikel
40 EP-1173 IMPACT OF PET-CT IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK (H&N) CANCER Sutmöller, V. Chicata
2012
103 Supplement 2 p. S452-
1 p.
artikel
41 EP-1293 IMPACT OF TIME OF DAY OF GAMMA KNIFE RADIOSURGERY ON SURVIVAL FOR NON-SMALL CELL LUNG CANCER BRAIN METASTASES Badiyan, S.N.
2012
103 Supplement 2 p. S491-S492
2 p.
artikel
42 EP-1605 IMPLEMENTING INTERVENTIONAL BRACHYTHERAPY IN A COMBINED 1.5 TESLA MRI/HDR TREATMENT ROOM; THE ROLE OF THE RTT Schokker, R.
2012
103 Supplement 2 p. S615-
1 p.
artikel
43 EP-1358 IMPROVING DOSE CALCULATIONS ON TOMOTHERAPY MVCT IMAGES Lacornerie, T.
2012
103 Supplement 2 p. S515-
1 p.
artikel
44 EP-1444 IMRT QA PROCEDURES FOR THE RTOG 0933 STUDY PROTOCOL: POTENTIAL IMPLICATION FOR ONGOING AND PLANNED EORTC RT-STUDIES? Eberle, B.
2012
103 Supplement 2 p. S550-S551
2 p.
artikel
45 EP-1341 INCIDENCE OF SIGNIFICANT DEVIATION BETWEEN RAYTRACING AND MONTE CARLO DOSE CALCULATION OF LUNG TUMORS Otahal, B.
2012
103 Supplement 2 p. S509-S510
2 p.
artikel
46 EP-1163 INCIDENCE OF TOXICITY IN LOCALLY ADVANCED HEAD? NECK CANCER PTS (LAHNSCC) TREATED WITH CETUXIMAB PLUS RADIOTHERAPY Prieto, I.
2012
103 Supplement 2 p. S448-S449
2 p.
artikel
47 EP-1276 INTENSITY MODULATED RADIATION THERAPY FOR RETROPERITONEAL SARCOMA El-Bared, N.
2012
103 Supplement 2 p. S486-
1 p.
artikel
48 EP-1577 INTERPLAY AMONG INTERLEUKIN EXPRESSION, PARENCHYMA AND INFLAMMATORY CELLS IN LATE RADIATION-INDUCED LUNG EFFECTS Williams, J.
2012
103 Supplement 2 p. S605-
1 p.
artikel
49 EP-1382 LATERAL ELECTRON SPREAD AS AN ENERGY VERIFICATION METHOD McCavana, P.
2012
103 Supplement 2 p. S524-S525
2 p.
artikel
50 EP-1204 MARKERS OF TREATMENT OUTCOME FOR PATIENTS WITH HEAD AND NECK CANCER WHO UNDERWENT RADIOTHERAPY Rutkowski, T.
2012
103 Supplement 2 p. S463-
1 p.
artikel
51 EP-1574 MODELLING EFFECTS OF INTERCELLULAR COMMUNICATION ON CELL SURVIVAL AFTER MODULATED RADIATION EXPOSURE McMahon, S.J.
2012
103 Supplement 2 p. S603-S604
2 p.
artikel
52 EP-1488 NEW CONCRETE DESIGNED SPECIFICALLY FOR NEUTRON SHIELDING Mera, M.
2012
103 Supplement 2 p. S568-
1 p.
artikel
53 EP-1235 NEW HIGH DENSITY BOLUS: A NEW APPROACH TO TREATMENT OF SUPERFICIAL TUMORS WITH PHOTONS Ortiz-Seidel, M.
2012
103 Supplement 2 p. S473-S474
2 p.
artikel
54 EP-1060 PATIENT AND HEALTH PROFESSIONAL QUESTIONNAIRES TO RECORD TREATMENT TOXICITY FOR OESOPHAGEAL CANCER Whitfield, G.
2012
103 Supplement 2 p. S413-
1 p.
artikel
55 EP-1084 PHASE II STUDY OF HELICAL TOMOTHERAPY IN THE MULTIDISCIPLINARY TREATMENT OF OLIGOMETASTATIC COLORECTAL CANCER Engels, B.
2012
103 Supplement 2 p. S420-
1 p.
artikel
56 EP-1115 RADICAL PROSTATE RADIOTHERAPY TO M0 PATIENTS WITH A PRESENTING PSA OF MORE THAN 100 Walker, G.A.
2012
103 Supplement 2 p. S431-
1 p.
artikel
57 EP-1015 RADIOTHERAPY AND ADJUVANT TRASTUZUMAB FOR HER-2 BREAST CANCER: CLINICAL OUTCOME AND CARDIOTOXICITY Vinante, L.
2012
103 Supplement 2 p. S399-
1 p.
artikel
58 EP-1101 RECTAL AIR REMOVAL REDUCES RECTAL CROSS-SECTIONAL AREA BUT DOESN'T MODIFY CENTER OF MASS OF PELVIC ORGANS Sabater, S.
2012
103 Supplement 2 p. S425-S426
2 p.
artikel
59 EP-1043 REIRRADIATION FOR RECURRENT MALIGNANT BRAIN TUMOR WITH X-RAY RADIOTHERAPY OR PROTON BEAM THERAPY Koji, T.
2012
103 Supplement 2 p. S408-
1 p.
artikel
60 EP-1279 RESPONSE OF RETROPERITONEAL SARCOMAS TO PRE-OPERATIVE RADIOTHERAPY Wong, P.
2012
103 Supplement 2 p. S487-
1 p.
artikel
61 EP-1087 RESULTS FROM A PHASE II NON RANDOMIZED TRIAL ON 145 PATIENTS WITH HEPATO-CELLULAR CARCINOMA WITH VMAT Wang, P.
2012
103 Supplement 2 p. S421-
1 p.
artikel
62 EP-1221 RESULTS OF CONCURRENT HYPERFRACTIONATED CHEMO-RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER (LD-SCLC) Monne, J. Sole
2012
103 Supplement 2 p. S469-
1 p.
artikel
63 EP-1026 ROLE OF PERCENT RESPONSE EVALUATION CRITERIA AFTER FIRST-LINE CHEMOTHERAPY IN COMBINED THERAPY HODGKIN LYMPHOMA Datsenko, P.V.
2012
103 Supplement 2 p. S402-
1 p.
artikel
64 EP-1132 SALVAGE STEREOTACTIC BODY RADIOTHERAPY FOR PATIENTS WITH LIMITED PROSTATE CANCER METASTASES De Meerleer, G.
2012
103 Supplement 2 p. S436-S437
2 p.
artikel
65 EP-1327 SETUP PROCEDURE TO ESTABLISH AN EPID BASED COLLIMATION SYSTEM QA IN A SIEMENS ARTISTE LINAC Ferradás, B.C. Portas
2012
103 Supplement 2 p. S504-
1 p.
artikel
66 EP-0981 SIMULTANEOUS INTEGRATED BOOST BREAST CANCER – A SUITABLE OPTION? Piefel, K.
2012
103 Supplement 2 p. S387-S388
2 p.
artikel
67 EP-1533 STEREOTACTIC BODY RADIATION THERAPY DELIVERED USING VOLUMETRIC MODULATED ARC THERAPY IN EARLY PROSTATE CANCER Murray, L.J.
2012
103 Supplement 2 p. S588-
1 p.
artikel
68 EP-1608 SURVIVAL AMONG PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION Wiinholdt, D.
2012
103 Supplement 2 p. S616-
1 p.
artikel
69 EP-1029 SURVIVAL AND PROGNOSTIC FACTORS IN GLIOBLASTOMA MULTIFORME Feltes, N.
2012
103 Supplement 2 p. S403-S404
2 p.
artikel
70 EP-1310 TC99M-TILMANOCEPT, A CD206 ILM AGENT, HAS >24HR STABILITY IN NODES & CONCORDANCE W/IMAGING IN BREAST CANCER Cope, F.
2012
103 Supplement 2 p. S497-
1 p.
artikel
71 EP-1566 TESTING FOR BRACA1 AND BRACA 2 GERMLINE MUTATION UNAFFECTED MEMBERS IN FAMILIES WITH BREAST/OVARIAN CANCER Eljuga, D.
2012
103 Supplement 2 p. S601-
1 p.
artikel
72 EP-1485 THE ONLINE STUDY PROGRAM “MASTER OF ADVANCED PHYSICAL METHODS IN RADIOTHERAPY (APMR)” Jäkel, O.
2012
103 Supplement 2 p. S567-
1 p.
artikel
73 EP-1183 TREATMENT OF HEAD-NECK CANCER PATIENTS USING CONPAS TECHNIQUE. 2 YEARS FOLLOW UP RESULTS Kovacs, A.
2012
103 Supplement 2 p. S455-S456
2 p.
artikel
74 EP-1252 TREATMENT OUTCOME AND ACUTE TOXICITIES AFTER BONE MARROW TRANSPLANTATION WITH THE USE OF TOTAL BODY IRRADIATION Szulc, A.
2012
103 Supplement 2 p. S479-
1 p.
artikel
75 EP-1146 VOLUMETRIC MODULATED ARC/STEREOTACTIC BODY RADIOTHERAPY IN PATIENTS UNSUITABLE FOR GYNECOLOGICAL BRACHYTHERAPY Patil, N.
2012
103 Supplement 2 p. S441-
1 p.
artikel
76 EP-1298 2 YEAR RESULTS OF LUNG SBRT FOR MEDICALLY INOPERABLE PERIPHERAL STAGE I NSCLC AT ST. JAMESÍS INSTITUTE OF ONCOLOGY. Ramasamy, S.
2012
103 Supplement 2 p. S493-
1 p.
artikel
77 18 20 EURAMET PROJECT: NEW CALIBRATION STANDARDS IN BRACHY-THERAPY Sander, T.
2012
103 Supplement 2 p. S7-S8
2 p.
artikel
78 Fat necrosis in women with early-stage breast cancer treated with accelerated partial breast irradiation (APBI) using interstitial brachytherapy Budrukkar, Ashwini
2012
103 Supplement 2 p. 161-165
5 p.
artikel
79 Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study Charra-Brunaud, Claire
2012
103 Supplement 2 p. 305-313
9 p.
artikel
80 Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy Levitchi, Mihai
2012
103 Supplement 2 p. 314-321
8 p.
artikel
81 Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004–03 Toledano, Ivan
2012
103 Supplement 2 p. 57-62
6 p.
artikel
82 1 INTRODUCTION Haie-Meder, C.
2012
103 Supplement 2 p. S1-
1 p.
artikel
83 Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature Seemann, Ingar
2012
103 Supplement 2 p. 143-150
8 p.
artikel
84 Kinomic profiling approach identifies Trk as a novel radiation modulator Jarboe, John S.
2012
103 Supplement 2 p. 380-387
8 p.
artikel
85 116 MODEL-BASED DOSE CALCULATION TECHNIQUES IN BRACHYTHERAPY Beaulieu, L.
2012
103 Supplement 2 p. S46-S47
2 p.
artikel
86 4 MRI: IMPACT ON BRACHYTHERAPY Jurgenliemk-Schulz, I.M.
2012
103 Supplement 2 p. S2-
1 p.
artikel
87 OC-0124 CHEMO-RADIATION IN ADVANCED STAGE CARCINOMA CERVIX. A PHASE III RANDOMIZED TRIAL: RESULTS OF 1ST INTERIM ANALYSIS Mahantshetty, U.
2012
103 Supplement 2 p. S48-S49
2 p.
artikel
88 OC-143 COMPARISON OF DIFFERENT FRACTIONATION SCHEDULES IN HDR BRACHYTHERAPY AS MONOTHERAPY FOR LOW-RISK PROSTATE CANCER Mavroidis, P.
2012
103 Supplement 2 p. S58-S59
2 p.
artikel
89 OC-85 DEFORMATION ANALYSIS OF PDR BRACHYTHERAPY IN CERVICAL CARCINOMA Cuartero, J.
2012
103 Supplement 2 p. S34-S35
2 p.
artikel
90 OC-0165 DEVELOPMENT OF A PRACTICAL PREDICTION MODEL FOR OVERALL SURVIVAL FROM STAGE III LUNG CANCER Lambin, P.
2012
103 Supplement 2 p. S63-S64
2 p.
artikel
91 OC-0062 3D IN VIVO VERIFICATION OF VMAT TREATMENTS USING EPID DOSIMETRY Rozendaal, R.A.
2012
103 Supplement 2 p. S25-
1 p.
artikel
92 OC-68 DOSIMETRIC CHARACTERIZATION OF SURFACE APPLICATORS USED WITH BRACHYTHERAPY SOURCES Fulkerson, R.
2012
103 Supplement 2 p. S26-S27
2 p.
artikel
93 OC-0391 EVALUATION OF CT ATLAS-BASED SEGMENTATION OF WHOLE BODYÍS ORGANS FOR LARGE FIELDS IRRADIATION Lamanna, G.
2012
103 Supplement 2 p. S157-
1 p.
artikel
94 OC-0388 HIF PATHWAY INHIBITION RESOLVES TUMOUR HYPOXIA AND IMPROVES LOCAL TUMOUR CONTROL AFTER IRRADIATION Helbig, L.
2012
103 Supplement 2 p. S156-
1 p.
artikel
95 OC-140 INFLUENCE OF HIGH ATOMIC NUMBER ELEMENTS IN HUMAN TISSUE IN DOSIMETRY FOR LOW ENERGY PHOTON BRACHYTHERAPY White, S.A.
2012
103 Supplement 2 p. S57-
1 p.
artikel
96 OC-54 LONG TERM OUTCOMES OF INTERSTITIAL BRACHYTHERAPY IN SOFT TISSUE SARCOMAS Laskar, S.
2012
103 Supplement 2 p. S21-S22
2 p.
artikel
97 OC-0227 MRI-BASED PLANNING FOR ONE-STOP-SHOP IRRADIATION OF VERTEBRAL METASTASES: A FEASIBILITY STUDY Brunenberg, E.J.L.
2012
103 Supplement 2 p. S89-
1 p.
artikel
98 OC-0463 NODAL CTV DEFORMATION CANNOT BE NEGLECTED IN HIGHLY CONFORMAL RADIOTHERAPY OF CERVICAL CANCER PATIENTS Velema, L.A.
2012
103 Supplement 2 p. S185-S186
2 p.
artikel
99 OC-51 OUTCOME AND TOXICITY PROFILE AFTER BRACHYTHERAPY FOR SQUAMOUS CELL CARCINOMA OF THE NASAL VESTIBULE. Lipman, D.
2012
103 Supplement 2 p. S21-
1 p.
artikel
100 OC-0453 POSITIONAL VARIATION OF INVOLVED MESORECTAL LYMPH NODES DURING RT OF RECTAL CANCER Hollmann, B.
2012
103 Supplement 2 p. S181-
1 p.
artikel
101 OC-82 PREPLANNING IMPROVES FEASIBILITY OF INTRACAVITARY/INTERSTITIEL BRACHYTHERAPY IN CERVICAL CANCER. Fokdal, L.
2012
103 Supplement 2 p. S33-S34
2 p.
artikel
102 OC-0477 RANDOM FOREST VERSUS PUBLISHED NTCP MODELS FOR RECTAL TOXICITY PREDICTION Ospina, J.D.
2012
103 Supplement 2 p. S191-S192
2 p.
artikel
103 OC-0405 REPORTING OF LATE RECTAL AND URINARY BLADDER SIDE EFFECTS AFTER MRI GUIDED ADAPTIVE BRACHYTHERAPY OF CERVIX CANCER Georg, P.
2012
103 Supplement 2 p. S162-
1 p.
artikel
104 OC-0049 THE IMPACT OF COMORBIDITIES ON THE BENEFITS OF PROLONGED ANDROGEN ABLATION IN PATIENTS WITH T3-4 PROSTATE CANCER Tyldesley, S.
2012
103 Supplement 2 p. S19-
1 p.
artikel
105 OC-37 THE PROSTATE TUMORLET PROJECT. CRITICAL ANALYSIS OF D90: TILTING AT WINDMILLS? Todor, D.
2012
103 Supplement 2 p. S15-S16
2 p.
artikel
106 OC-0076 UK NATIONAL VOLUNTARY REPORTING AND ANALYSIS OF RADIOTHERAPY ERRORS AND NEAR MISSES (2009–2011) O'Doherty, U.
2012
103 Supplement 2 p. S30-
1 p.
artikel
107 PD-0210 ADJUVANT RADIOTHERAPY IMPROVES LOCAL CONTROL AND SURVIVAL IN PATIENTS WITH UTERINE LEIOMYOSARCOMA Han, K.
2012
103 Supplement 2 p. S81-
1 p.
artikel
108 PD-0035 ARRAY DOSIMETRY CUSTOMIZED FOR STEREOTACTIC RADIOSURGERY: SQUARE AIR CORE LIGHT GUIDE TECHNOLOGY Liu, P.Z.Y.
2012
103 Supplement 2 p. S13-S14
2 p.
artikel
109 PD-0330 BIOMECHANICAL DEFORMABLE REGISTRATION BASED DOSE ACCUMULATION VS. DOSE SUMMATION FOR THE BLADDER Andersen, E.S.
2012
103 Supplement 2 p. S131-S132
2 p.
artikel
110 PD-0244 CHALLENGES IN DEVELOPING RADIOTHERAPY PLANNING PROTOCOL FOR FUTURE UK STEREOTACTIC LIVER RADIOTHERAPY TRIALS Blasiak-Wal, I.
2012
103 Supplement 2 p. S97-S98
2 p.
artikel
111 PD-0316 CHARACTERISATION OF A HIGH-RESOLUTION 1-D OPTICAL SCANNER FOR GEL DOSIMETER SAMPLES Kinnari, T.S.
2012
103 Supplement 2 p. S125-S126
2 p.
artikel
112 PD-0299 CORRELATIONS OF SPATIAL DOSE DISTRIBUTION WITH TRISMUS IN A COHORT OF HEAD AND NECK RADIOTHERAPY PATIENTS Saleh, Z.
2012
103 Supplement 2 p. S118-
1 p.
artikel
113 PD-0285 EVALUATION OF TOLERANCE TO EXCLUSIVE IORT WITH DIFFERENT DOSES FOR CONSERVATIVE BREAST CANCER TREATMENT Fozza, A.
2012
103 Supplement 2 p. S112-
1 p.
artikel
114 PD-0347 EXTENDED PENUMBRA REDUCTION FOR NORMAL TISSUE SPARING IN PROTON THERAPY OF INTRACRANIAL TUMOR Bubula, M.
2012
103 Supplement 2 p. S139-
1 p.
artikel
115 PD-0302 IMPROVED RISK ASSESSMENT OF ENDOMETRIAL CANCER PATIENTS BY ANALYSIS OF MSI, PI3K-AKT, WNT AND P53 PATHWAY Nout, R.A.
2012
103 Supplement 2 p. S119-S120
2 p.
artikel
116 PD-0271 LOCAL SETUP REPRODUCIBILITY OF THE HEAD & NECK CANCER PATIENTS FOR TWO DIFFERENT NECK SUPPORTS IN CLINICAL PRACTICE van Beek, S.
2012
103 Supplement 2 p. S106-S107
2 p.
artikel
117 PD-0566 PREOPERATIVE CHEMORADIATION FOR UNRESECTABLE RECTAL CANCER: INTERIM ANALYSIS OF A MULTICENTRE RANDOMIZED STUDY Bujko, K.
2012
103 Supplement 2 p. S226-S227
2 p.
artikel
118 PD-0213 RETRO-EMBRACE: A MULTICENTRE RETROSPECTIVE STUDY OF IMAGE GUIDED ADAPTIVE BRACHYTHERAPY IN CERVICAL CANCER Sturdza, A.E.
2012
103 Supplement 2 p. S82-S83
2 p.
artikel
119 PD-0333 SETUP EFFICIENCY AND ACCURACY USING ALIGNRT V.4.5 AND V.5 3D REAL-TIME SURFACE IMAGING SYSTEM Peng, J.
2012
103 Supplement 2 p. S133-
1 p.
artikel
120 Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction Wu, Jackson S.Y.
2012
103 Supplement 2 p. 210-216
7 p.
artikel
121 Phase II trial of 3D-conformal accelerated partial breast irradiation: Lessons learned from patients and physicians’ evaluation Azoury, Fares
2012
103 Supplement 2 p. 193-198
6 p.
artikel
122 PO-0820 ACCURACY OF ELECTRON BEAM CALCULATIONS USING THE ECLIPSE EMC ALGORITHM FOR THORACIC WALL TREATMENT D'Olieslager, G.
2012
103 Supplement 2 p. S319-S320
2 p.
artikel
123 PO-0651 A COMPARATIVE STUDY OF VMAT (RAPIDARC) AND 3-D CONFORMAL RADIOTHERAPY FOR CRANIO-SPINAL IRRADIATION Alawi, T.
2012
103 Supplement 2 p. S254-S255
2 p.
artikel
124 PO-0954 ACUTE MORBIDITY IN PATIENTS WITH EARLY BREAST CANCER IN ADJUVANT RADIOTHERAPY IN THE DBCG HYPO AND DBCG PBI PROTOCOLS Haislund, B.
2012
103 Supplement 2 p. S375-S376
2 p.
artikel
125 PO-206 ACUTE TOXICITY OF SINGLE FRACTION BOOST WITH HDR BT AFTER HYPOFRACTIONATED EBRT FOR LOCALLY ADVANCED PROSTATE CANCER Murata, K.
2012
103 Supplement 2 p. S83-
1 p.
artikel
126 PO-189 A NOVEL IMAGE-FUSION TECHNIQUE BETWEEN CT AND T2-WEIGHTED MR IMAGES FOR POSTIMPLANT DOSIMETRY AFTER BRACHYTHERAPY Kunogi, H.
2012
103 Supplement 2 p. S77-
1 p.
artikel
127 PO-0865 A PHANTOM STUDY FOR THE VALIDATION OF AN IN-HOUSE DEFORMABLE REGISTRATION ALGORITHM FOR DOSE ACCUMULATION Zambrano, V.
2012
103 Supplement 2 p. S338-S339
2 p.
artikel
128 PO-0940 A TGFB1 SNP ASSOCIATED WITH QUALITY OF LIFE IMPAIRING TOXICITY IN PROSTATE CANCER PATIENTS TREATED WITH RADIOTHERAPY Rave-Fränk, M.
2012
103 Supplement 2 p. S370-S371
2 p.
artikel
129 PO-0669 BOWEL TOXICITY AFTER IMRT FOR PROSTATE CANCER WITH A SPACER GEL – A MATCHED-PAIR COMPARISON Pinkawa, M.
2012
103 Supplement 2 p. S261-
1 p.
artikel
130 PO-336 BRACHYTHERAPY ACTIVITIES IN THE FRAMEWORK OF THE EUROPEAN METROLOGY RESEARCH PROGRAMME Schneider, T.
2012
103 Supplement 2 p. S135-
1 p.
artikel
131 PO-278 BRACHYTHERAPY AS ORGAN PRESERVATION TREATMENT MODALITY FOR LOCALIZED / LOCALLY ADVANCED VULVAL CANCERS Mahantshetty, U.
2012
103 Supplement 2 p. S111-S112
2 p.
artikel
132 PO-412 BRACHYTHERAPY OF THE ORBIT IN YOUNG CHILDREN Sauerwein, W.
2012
103 Supplement 2 p. S164-
1 p.
artikel
133 PO-0745 CAN FDG PET DURING THE COURSE OF RADIATION THERAPY FOR LUNG CANCER PREDICT FOR ESOPHAGITIS AND PNEUMONITIS OUTCOME? McCloskey, P.
2012
103 Supplement 2 p. S289-
1 p.
artikel
134 PO-175 CATHETER POSITION CONTROL IN HIGH DOSE RATE BRACHYTHERAPY OF PROSTATE CANCER Marolt, P.
2012
103 Supplement 2 p. S71-S72
2 p.
artikel
135 PO-0683 CBCT ADAPTIVE PROTOCOL TO REDUCE PTV-RECTUM INTERSECTION IN THE PROSTATE RADIOTHERAPY Mantello, G.
2012
103 Supplement 2 p. S266-
1 p.
artikel
136 PO-0851 CLINICAL VALIDATION OF ATLAS-BASED AUTO-SEGMENTATION OF PELVIC VOLUMES AND NORMAL TISSUE IN RECTAL TUMORS Gambacorta, M.A.
2012
103 Supplement 2 p. S332-S333
2 p.
artikel
137 PO-384 COMBINED EXTERNAL BEAM RADIOTHERAPY AND INTRALUMINAL BRACHYTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER Scepanovic, D.
2012
103 Supplement 2 p. S153-
1 p.
artikel
138 PO-0878 COMPARISON OF TWO MLC QA APPROACHES: INDIVIDUAL LEAF ANALYSIS OR GLOBAL PERFORMANCE? Latorre Musoll, A.
2012
103 Supplement 2 p. S344-S345
2 p.
artikel
139 PO-323 COSMETIC OUTCOME AFTER INTRA-OPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER IN WOMEN OVER 50 YEARS Williams, N.
2012
103 Supplement 2 p. S128-S129
2 p.
artikel
140 PO-172 CURRENT RISK CLASSIFICATION FOR PROSTATE CANCER DOES NOT ACCURATELY PREDICT SURVIVAL AFTER I-125 BRACHYTHERAPY Kerkmeijer, L.
2012
103 Supplement 2 p. S70-S71
2 p.
artikel
141 PO-0786 4-DIMENSIONAL COMPUTED TOMOGRAPHY IN ACCELERATED PARTIAL BREAST IRRADIATION PLANNING Meattini, I.
2012
103 Supplement 2 p. S305-
1 p.
artikel
142 PO-220 DOSE ESCALATION TO 160 GY IN I-125 PROSTATE IMPLANTS. EARLY CLINICAL RESULTS Tormo, A.
2012
103 Supplement 2 p. S88-
1 p.
artikel
143 PO-0875 DOSIMETRIC AUDIT IN A MULTICENTRE PHASE III TRIAL OF SURGERY VERSUS STEREOTACTIC RADIOTHERAPY FOR LUNG CANCER Cuijpers, J.P.
2012
103 Supplement 2 p. S343-
1 p.
artikel
144 PO-295 DOSIMETRIC GAIN OF UTRECHT INTERSTITIAL CT/MRI APPLICATOR IN CERVICAL CANCER HDR-BRACHYTHERAPY Camacho, C.
2012
103 Supplement 2 p. S118-
1 p.
artikel
145 PO-309 DOSIMETRIC IMPACT OF INTERFRACTION CATHETER MOVEMENT IN MRI CT GUIDED HDR INTERSTITIAL BRACHYTHERAPY FOR GYN CANCER Rey, F.
2012
103 Supplement 2 p. S123-S124
2 p.
artikel
146 PO-0834 DOSIMETRIC VERIFICATION OF VMAT WITH COMPASSÆ: INFLUENCE OF VMAT ARC DISCRETIZATION Ausma, A.H.
2012
103 Supplement 2 p. S325-
1 p.
artikel
147 PO-0957 EFFECT OF A DIETARY PROTOCOL ON RECTAL SIZE DURING RADICAL RADIOTHERAPY FOR PROSTATE CANCER Buckley, S.
2012
103 Supplement 2 p. S377-
1 p.
artikel
148 PO-0967 EVALUATION OF INGUINAL REGION SET-UP ACCURACY USING CONE-BEAM CT IN ANAL CANCER PATIENTS TREATED WITH IMRT Johnston, M.
2012
103 Supplement 2 p. S381-
1 p.
artikel
149 PO-0789 EVALUATION OF THREE COMMERCIAL SOFTWARE SOLUTIONS FOR AUTOMATIC SEGMENTATION FOR REDELINEATION OF TARGET AND OARS La Macchia, M.
2012
103 Supplement 2 p. S306-
1 p.
artikel
150 PO-0665 EVIDENT ESOPHAGEAL TUMOUR PROGRESSION BETWEEN THE DIAGNOSTIC FDG-PET AND THE FDG-PET FOR RADIOTHERAPY PLANNING Muijs, C.T.
2012
103 Supplement 2 p. S259-
1 p.
artikel
151 PO-326 FAST MONTE CARLO HDR DOSE CALCULATIONS WITH BGPUMCD Hissoiny, S.
2012
103 Supplement 2 p. S129-S130
2 p.
artikel
152 PO-0637 HOW FEASIBLE IS NODAL IRRADIATION WITH TANGENTIAL FIELDS IN BREAST CANCER? A COMPARATIVE TECHNIQUE STUDY Sanz, J.
2012
103 Supplement 2 p. S250-
1 p.
artikel
153 PO-0906 HYPOFRACTIONATED PROSTATE RADIOTHERAPY AND RECTAL TOXICITY: DOES RECTAL OUTLINE MATTER? McPartlin, A.
2012
103 Supplement 2 p. S357-
1 p.
artikel
154 PO-264 INITIAL CLINICAL FOLLOW-UP ON THE USE OF A CO-60 HDR SOURCE FOR CERVICAL CANCER BRACHYTHERAPY Nagar, Y.
2012
103 Supplement 2 p. S106-
1 p.
artikel
155 PO-350 INTENSE LEARNING OUTCOMES BASED BRACHYTHERAPY TRAINING FOR RADIATION ONCOLOGY MEDICAL PHYSICISTS Flower, E.
2012
103 Supplement 2 p. S141-
1 p.
artikel
156 PO-0703 IS THE OVER-EXPRESSION OF COX-2 REALLY A FACTOR OF POOR PROGNOSIS IN CERVICAL CANCER? Aylas, M.
2012
103 Supplement 2 p. S273-S274
2 p.
artikel
157 PO-415 LOCAL CONTROL, SURVIVAL AND COMPLICATIONS OF SOFT TISSUE SARCOMAS TREATED WITH LOW OR HIGH DOSE RATE BRACHYTHERAPY Paul, A.
2012
103 Supplement 2 p. S165-
1 p.
artikel
158 PO-0803 LOW MU FIELDS, SIMULATION AND ASSESSMENT OF PORTAL IMAGES FOR 3 ACCELERATORS: CONSEQUENCES ON 2D PORTAL DOSIMETRY Podesta, M.
2012
103 Supplement 2 p. S311-S312
2 p.
artikel
159 PO-0750 MATURE RESULTS OF A PHASE 2 DOSE-ESCALATION STUDY IN UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER Collen, C.
2012
103 Supplement 2 p. S290-S291
2 p.
artikel
160 PO-0923 MID-VENTILATION PHASE FOR CALCULATION OF TREATMENT PLAN FOR LUNG CANCER PATIENTS MIGHT NOT BE OPTIMAL Brink, C.
2012
103 Supplement 2 p. S364-
1 p.
artikel
161 PO-0714 NASOPHARYNGEAL CANCER: TREATMENT TECHNIQUE, DOSE HOMOGENEITY AND ACUTE TOXICITY IN AN ITALIAN PROSPECTIVE STUDY Tonoli, S.
2012
103 Supplement 2 p. S277-S278
2 p.
artikel
162 PO-292 OUTCOMES FOR CERVICAL AND VAGINAL CANCER WITH HDR INTERSTITIAL BRACHYTHERAPY UTILIZING MRI BASED PLANNING Freilich, J.M.
2012
103 Supplement 2 p. S117-
1 p.
artikel
163 PO-158 PHASE II TRIAL OF HIGH-DOSE RATE BRACHYTHERAPY AND EXTERNAL RADIATION FOR INTERMEDIATE-RISK PROSTATE CANCER Tsukiyama, I.
2012
103 Supplement 2 p. S65-
1 p.
artikel
164 PO-0717 PREDICTING LONG TERM PEG DEPENDENCE AFTER IMRT +/− CONCOMITANT CHEMOTHERAPY FOR OROPHARYNGEAL CANCER Sanguineti, G.
2012
103 Supplement 2 p. S279-
1 p.
artikel
165 PO-0634 PREDICTIVE FACTORS FOR LUNG INJURY AFTER INTENSITY-MODULATED RADIOTHERAPY IN WHOLE BREAST IRRADIATION Kim, H.
2012
103 Supplement 2 p. S249-
1 p.
artikel
166 PO-381 PREDICTIVE MODEL OF COMPLICATIONS AFTER PERIOPERATIVE HIGH DOSE RATE BRACHYTHERAPY San Miguel, I.
2012
103 Supplement 2 p. S152-
1 p.
artikel
167 PO-0700 PROGNOSTIC VALUE OF SQUAMOUS CELL CARCINOMA ANTIGEN (SCC) IN CERVICAL CANCER MANAGED WITH CHEMO-RADIOTHERAPY Gomez, S.
2012
103 Supplement 2 p. S272-S273
2 p.
artikel
168 PO-0762 QUALITY OF LIFE OUTCOMES IN PATIENTS TREATED FOR GYNAECOLOGICAL CANCER USING THE EORTC QUESTIONNAIRE Pisani, C.
2012
103 Supplement 2 p. S295-
1 p.
artikel
169 PO-398 RADIOACTIVITY SEEDS INTERSTITIAL BRACHYTHERAPY TREATING MALIGNANT SALIVARY GLAND TUMORS Zhang, J.
2012
103 Supplement 2 p. S158-
1 p.
artikel
170 PO-0681 REACHING PSA NADIR UNDER 0.35 NG/ML AFTER 2 YEARS FOLLOWING BRACHYTHERAPY PREDICTS BIOCHEMICAL CONTROL Guarneri, A.
2012
103 Supplement 2 p. S265-
1 p.
artikel
171 PO-203 RECTUM PRESERVATION BY BOLUS HYALURONAN INJECTION INTO PERI/PARA RECTAL SPACE DURING HDR-BT OF PROSTATE CANCER Kishi, K.
2012
103 Supplement 2 p. S82-
1 p.
artikel
172 PO-0772 RESPONSE PATTERNS WITH POSITRON EMISSION TOMOGRAPHY AFTER STEREOTACTIC RADIOTHERAPY OF MALIGNANT LUNG LESIONS Sandhu, A.
2012
103 Supplement 2 p. S298-S299
2 p.
artikel
173 PO-0748 SENSITIVITY OF TEXTURAL AND SHAPE FEATURES IN CT IMAGES TO TUMOR DEFINITION Carvalho, S.
2012
103 Supplement 2 p. S290-
1 p.
artikel
174 PO-0837 STATISTICAL CONTROL OF BEAM FLATNESS AND SYMMETRY IN LINEAR ACCELERATORS: DIFFERENCES BETWEEN PROTOCOLS Tornero-López, A.
2012
103 Supplement 2 p. S326-S327
2 p.
artikel
175 PO-247 STUDY OF MR IMAGE BASED INTERSTITIAL BRACHYTHERAPY USING THERMOPLASTIC CATHETER FOR ADVANCED CERVICAL CANCER Palled, S.
2012
103 Supplement 2 p. S99-S100
2 p.
artikel
176 PO-0892 TARGET SURFACE BASED FLUENCE DEFORMATION, FOR ADAPTIVE INTENSITY MODULATED RADIOTHERAPY Crijns, W.
2012
103 Supplement 2 p. S350-S351
2 p.
artikel
177 PO-0909 TCP- AND EUD-BASED DOSE-PAINTING OF PROSTATE TUMOURS TO ACCOUNT FOR SPATIAL CLONOGEN DISTRIBUTION Iori, M.
2012
103 Supplement 2 p. S358-
1 p.
artikel
178 PO-367 THE DIFFERENT BIOLOGICAL EFFECTS OF SINGLE, FRACTIONED AND CLDR IRRADIATION IN CL187 COLORECTAL CANCER CELLS Wang, H.
2012
103 Supplement 2 p. S148-
1 p.
artikel
179 PO-210 URINARY ENGRAILED-2: A NOVEL BIOMARKER FOR FOLLOW UP POST RADICAL TREATMENT FOR PROSTATE CANCER Javed, S.
2012
103 Supplement 2 p. S85-
1 p.
artikel
180 PO-261 UTERINE PERFORATION DURING INTRACAVITARY BRACHYTHERAPY FOR GYNECOLOGICAL MALIGNANCIES Segedin, B.
2012
103 Supplement 2 p. S105-
1 p.
artikel
181 PO-0731 WHICH FACTORS AFFECT THE PATIENTS QUALITY OF LIFE DURING THE COURSE OF RADIOTHERAPY FOR HEAD AND NECK CANCER? Milecki, P.
2012
103 Supplement 2 p. S284-
1 p.
artikel
182 Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer Barraclough, Lisa H.
2012
103 Supplement 2 p. 327-332
6 p.
artikel
183 Quality assurance in the EORTC 22033–26033/CE5 phase III randomized trial for low grade glioma: The digital individual case review Fairchild, Alysa
2012
103 Supplement 2 p. 287-292
6 p.
artikel
184 Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines Boersma, Liesbeth J.
2012
103 Supplement 2 p. 178-182
5 p.
artikel
185 Results of carbon ion radiotherapy for head and neck cancer Mizoe, Jun-etsu
2012
103 Supplement 2 p. 32-37
6 p.
artikel
186 99 RIGID RECTOSCOPY TO IMPROVE RADIATION TARGETING AND INDIVIDUALISE MANAGEMENT OF RECTAL CANCER Gérard, J.P.
2012
103 Supplement 2 p. S39-
1 p.
artikel
187 2 ROLE OF FUNCTIONAL IMAGING Carey, B.
2012
103 Supplement 2 p. S1-
1 p.
artikel
188 SP-0052 ADAPTIVE RADIOTHERAPY OF HEAD AND NECK CANCER, WITH INTEGRATION OF BIOLOGICAL INFORMATION Grau, C.
2012
103 Supplement 2 p. S20-S21
2 p.
artikel
189 SP-0141 AGAINST THE MOTION Aird, E.
2012
103 Supplement 2 p. S54-
1 p.
artikel
190 SP-0155 AGAINST THE MOTION Osztavics, A.
2012
103 Supplement 2 p. S60-
1 p.
artikel
191 SP-0539 ARTFORCE CONSORTIUM: AN UPDATE Rasch, C.
2012
103 Supplement 2 p. S215-S216
2 p.
artikel
192 SP-0511 ASSESSMENT OF EFFECT AND OUTCOME Greco, C.
2012
103 Supplement 2 p. S205-
1 p.
artikel
193 SP-0018 BIOLOGICAL ADAPTATION STRATEGIES Kaanders, J.H.A.M.
2012
103 Supplement 2 p. S5-S6
2 p.
artikel
194 SP-0508 BIOLOGICAL CONSIDERATION OF HIGH DOSE PER FRACTION Paris, F.
2012
103 Supplement 2 p. S204-S205
2 p.
artikel
195 SP-0182 COMBINED TREATEMENT RECTAL: YOUNG ADULT PATIENTS Rutten, H.
2012
103 Supplement 2 p. S70-
1 p.
artikel
196 SP-0419 COMPLEX MULTI-MODAL APPROACHES FOR OESOPHAGUS AND OGJ TUMOURS Gunderson, L.
2012
103 Supplement 2 p. S167-
1 p.
artikel
197 SP-0138 CONCLUSIONS FOR THE MOTION – BRACHYTHERAPY IS THE BEST TECHNIQUE FOR PARTIAL BREAST IRRADIATION Polgar, C.
2012
103 Supplement 2 p. S54-
1 p.
artikel
198 SP-0196 DOSE RECONSTRUCTION IN TOMOTHERAPY Moeckli, R.
2012
103 Supplement 2 p. S76-
1 p.
artikel
199 SP-0258 EMERGING IMAGING TECHNOLOGIES? HOW FUNCTIONAL IMAGING WILL IMPACT ON OUR PRACTICE. BRAIN TUMORS Grosu, A.
2012
103 Supplement 2 p. S102-
1 p.
artikel
200 SP-0093 ETHICAL VALUES IN MANAGING A DEPARTMENT Van Daele, B.
2012
103 Supplement 2 p. S37-S38
2 p.
artikel
201 SP-0450 HOW TO IMPROVE THE THERAPEUTIC RATIO FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LANSCLC) Komaki, R.
2012
103 Supplement 2 p. S179-S180
2 p.
artikel
202 SP-0436 HYPERFRACTIONATION: RADIOBIOLOGICAL BASIS FOR CLINICAL PRACTICE Rutkowski, T.
2012
103 Supplement 2 p. S173-S174
2 p.
artikel
203 SP-0620 ICORG 09-06 AN ONGOING PROSPECTIVE RANDOMISED TRIAL COMPARING 3D RT WITH IMRT FOR THE TREATMENT OF ENDOMETRIAL CANCER O'Sullivan, L.
2012
103 Supplement 2 p. S243-
1 p.
artikel
204 SP-0004 IMAGE-GUIDED ADAPTIVE RADIOTHERAPY (IGART): STATE OF THE ART Glide-Hurst, C.
2012
103 Supplement 2 p. S2-
1 p.
artikel
205 SP-0525 IS THERE A NEED FOR INTERVAL BETWEEN DRUG AND RADIOTHERAPY DELIVERY? Herrera, F.
2012
103 Supplement 2 p. S211-
1 p.
artikel
206 SP-0107 NETWORKING AND CONNECTIVITY IN RADIOTHERAPY: OPPORTUNITIES AND RISKS van der Putten, W.
2012
103 Supplement 2 p. S42-
1 p.
artikel
207 SP-0584 PET-CT PREDICTION OF RESPONSE OF RECTAL CANCER TO NEO-ADJUVANT THERAPY: STANDARD OR RESEARCH? C.M. Deroose 2012
103 Supplement 2 p. S233-S234
2 p.
artikel
208 SP-0090 QUALITY AND SAFETY IN RADIOTHERAPY Scalliet, P.
2012
103 Supplement 2 p. S36-
1 p.
artikel
209 SP-0494 RADIATION CAN BE A SURGEONS BEST TOOL Naredi, P.
2012
103 Supplement 2 p. S198-S199
2 p.
artikel
210 SP-0556 SNPS WILL BE USEFUL PREDICTORS OF NORMAL TISSUE RESPONSE IN THE FUTURE – CONCLUSIONS FOR THE MOTION Parliament, M.
2012
103 Supplement 2 p. S222-S223
2 p.
artikel
211 SP-0602 STRATEGIES FOR EXPANDING RTT RESEARCH ACTIVITY Cox, J.
2012
103 Supplement 2 p. S238-
1 p.
artikel
212 SP-0422 THE CHALLENGE OF INTRODUCING BIOMARKERS IN PHASE 1-2†TRIALS UTILIZING RADIOTHERAPY AND NOVEL TARGETED AGENTS Hollywood, D.
2012
103 Supplement 2 p. S168-
1 p.
artikel
213 SP-0542 THE RISK OF SECOND CANCERS FOLLOWING PROTON THERAPY Trott, K.
2012
103 Supplement 2 p. S217-
1 p.
artikel
214 SP-0581 TREATING BRAIN METASTASES: CURRENT APPROACHES AND CONTROVERSIES Minniti, G.
2012
103 Supplement 2 p. S232-S233
2 p.
artikel
215 SP-0021 TREATMENT PLANNING: INTEGRATING ROBUSTNESS IN OPTIMIZATION Bortfeld, T.
2012
103 Supplement 2 p. S7-
1 p.
artikel
216 SP-0179 UPDATE ON NEUROBLASTOMA Gandola, L.
2012
103 Supplement 2 p. S68-S69
2 p.
artikel
217 SP-0268 VASCULAR AND METABOLIC RESPONSES TO TUMOR IRRADIATION Pruschy, M.
2012
103 Supplement 2 p. S105-
1 p.
artikel
218 SP-0374 WHAT CAN AUTOMATIC PET TUMOUR VOLUME DELINEATION BRING TO TREATMENT PLANNING? Visvikis, D.
2012
103 Supplement 2 p. S149-S150
2 p.
artikel
219 TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients Fachal, Laura
2012
103 Supplement 2 p. 206-209
4 p.
artikel
220 The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: An in silico planning comparative study van der Laan, Hans Paul
2012
103 Supplement 2 p. 76-81
6 p.
artikel
221 109 UPCOMING ICRU/GEC ESTRO RECOMMENDATIONS FOR BRACHYTHERAPY IN CANCER OF THE CERVIX (2) Kirisits, C.
2012
103 Supplement 2 p. S42-S43
2 p.
artikel
222 130 VAGINAL BRACHYTHERAPY SHOULD BE THE STANDARD ADJUVANT TREATMENT Creutzberg, C.L.
2012
103 Supplement 2 p. S52-S53
2 p.
artikel
                             222 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland